Location History:
- Caeseria, IL (2007)
- Caesarea, IL (2009)
Company Filing History:
2 out of 893 
2 out of 2 Years Active: 2007-2009
Title: Charles S. Irving: Innovator in Cancer Treatment
Introduction
Charles S. Irving, a notable inventor based in Caesarea, IL, has made significant contributions to the field of cancer treatment through his innovative inventions. With a total of two patents to his name, Irving's work focuses on utilizing viral strains for therapeutic purposes, particularly against cancer.
Latest Patents
Irving's latest patents highlight his groundbreaking methods using Newcastle Disease Virus (NDV) in cancer therapy. The first patent, titled "Compositions of NDV and methods of use thereof for treatment of cancer," discloses methods for inducing tumor regression by administering a pharmaceutical composition that includes a lentogenic strain of NDV, specifically the clonal strain NDV HUJ. This method is particularly advantageous for patients who do not respond to standard anti-cancer therapies. The second patent, "Compositions and methods for treatment of cancer," focuses on the use of lentogenic viral strains, emphasizing the particular strain of NDV. It introduces innovative treatment approaches utilizing isolated viral glycoproteins and polynucleotides for cancer treatment.
Career Highlights
Throughout his career, Charles S. Irving has collaborated with esteemed organizations such as the Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Theravir Management L.P. His endeavors in these companies have paved the way for advancements in cancer treatment methodologies and the application of viral therapies.
Collaborations
Irving has worked alongside notable coworkers, including Zichria Zakay-Rones and Amos Panet. These collaborations have played a crucial role in the development of his patents and the exploration of innovative approaches in medical science.
Conclusion
Charles S. Irving stands as a significant figure in the realm of medical inventions, particularly in the fight against cancer. His patented methods leveraging Newcastle Disease Virus demonstrate a promising future for cancer treatments, offering hope to patients who have exhausted conventional options. As research continues to evolve, Irving’s contributions may lead to transformative breakthroughs in oncology.